Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Boyer

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Frontiers in Immunology|November 10, 2025
Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adultsKwadwo Ansah Koram, Kathleen A Walker, Bonaventure Orizu, et al.
The Journal of Infectious Diseases|July 11, 2013
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for deliverySpyros A Kalams, Scott D Parker, Marnie Elizaga, et al.
The Journal of Infectious Diseases|October 11, 2018
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA VaccinesAmi Patel, Emma L Reuschel, Kimberly A Kraynyak, et al.
BMC Immunology|June 28, 2005
Standardization of cytokine flow cytometry assaysHolden T Maecker, Aline Rinfret, Patricia D'Souza, et al.
The Lancet. Infectious Diseases|July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trialKayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
Nature Communications|May 21, 2020
Immunogenicity of a DNA vaccine candidate for COVID-19Trevor R F Smith, Ami Patel, Stephanie Ramos, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Frontiers in Immunology|November 10, 2025
Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adultsKwadwo Ansah Koram, Kathleen A Walker, Bonaventure Orizu, et al.
The Journal of Infectious Diseases|July 11, 2013
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for deliverySpyros A Kalams, Scott D Parker, Marnie Elizaga, et al.
The Journal of Infectious Diseases|October 11, 2018
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA VaccinesAmi Patel, Emma L Reuschel, Kimberly A Kraynyak, et al.
BMC Immunology|June 28, 2005
Standardization of cytokine flow cytometry assaysHolden T Maecker, Aline Rinfret, Patricia D'Souza, et al.
The Lancet. Infectious Diseases|July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trialKayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
Nature Communications|May 21, 2020
Immunogenicity of a DNA vaccine candidate for COVID-19Trevor R F Smith, Ami Patel, Stephanie Ramos, et al.
Pageof 7